Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2005
Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743
S Marchini, E Marrazzo, R Bonomi, et al.
Cancer
|
December 26, 2001
A novel taxane active against an orthotopically growing human glioma xenograft
D Laccabue, M Tortoreto, S Veneroni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 17, 2009
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate
M Chiarini, A Sottini, C Ghidini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2006
Ghrelin secretion in preterm neonates progressively increases and is refractory to the inhibitory effect of food intake
S Bellone, R Baldelli, G Radetti, et al.
Multiple Sclerosis International
|
November 22, 2013
Growth hormone and disease severity in early stage of multiple sclerosis
M Gironi, C Solaro, C Meazza, et al.
Minerva Pediatrica
|
September 24, 2013
[What new fathers know, think and do: a survey about fathering's attitudes, beliefs and behaviors in a sample of 570 men just after the birth of their newborn]
A Pellai, F Festa, F Cilento, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 12, 2006
Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral c-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors
R Frapolli, E Marangon, M Zaffaroni, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
March 1, 1997
[Malformations of the midline. A case-control study]
A Guala, G Pastore, P Cerruti Mainardi, et al.
Neurology
|
September 8, 2010
Safety and efficacy of natalizumab in children with multiple sclerosis
A Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Neurology
|
June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients
F L Sciacca, C Ferri, K Vandenbroeck, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
European Journal of Cancer (Oxford, England : 1990)
|
January 22, 2005
Molecular characterisation of two human cancer cell lines selected in vitro for their chemotherapeutic drug resistance to ET-743
S Marchini, E Marrazzo, R Bonomi, et al.
Cancer
|
December 26, 2001
A novel taxane active against an orthotopically growing human glioma xenograft
D Laccabue, M Tortoreto, S Veneroni, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 17, 2009
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate
M Chiarini, A Sottini, C Ghidini, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2006
Ghrelin secretion in preterm neonates progressively increases and is refractory to the inhibitory effect of food intake
S Bellone, R Baldelli, G Radetti, et al.
Multiple Sclerosis International
|
November 22, 2013
Growth hormone and disease severity in early stage of multiple sclerosis
M Gironi, C Solaro, C Meazza, et al.
Minerva Pediatrica
|
September 24, 2013
[What new fathers know, think and do: a survey about fathering's attitudes, beliefs and behaviors in a sample of 570 men just after the birth of their newborn]
A Pellai, F Festa, F Cilento, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 12, 2006
Pharmacokinetics and metabolism in mice of IDN 5390 (13-(N-Boc-3-i-butylisoserinoyl)-C-7,8-seco-10-deacetylbaccatin III), a new oral c-seco-taxane derivative with antiangiogenic property effective on paclitaxel-resistant tumors
R Frapolli, E Marangon, M Zaffaroni, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics
|
March 1, 1997
[Malformations of the midline. A case-control study]
A Guala, G Pastore, P Cerruti Mainardi, et al.
Neurology
|
September 8, 2010
Safety and efficacy of natalizumab in children with multiple sclerosis
A Ghezzi, C Pozzilli, L M E Grimaldi, et al.
Neurology
|
June 17, 1999
Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients
F L Sciacca, C Ferri, K Vandenbroeck, et al.
Page
of 14